Killing efficacy and anti-biofilm activity of synthetic human cationic antimicrobial peptide cathelicidin hCAP-18/LL37 against urinary tract pathogens
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2015, Vol 5, Issue 1
Abstract
Objectives: Cathelicidin LL37 represents one of the chemical defence components of bladder epithelial cells that include antimicrobial peptides, which also shown to have an important role in the mucosal immunity of the urinary tract by preventing adhesion of bacteria. This study aimed to determine the killing efficacy of LL37 compared to anti-biofilm activity against Staphylococcus aureus and Escherichia coli. Methods: The 96-flat well microtiter plates were used for evaluation of killing rate by estimation of MIC-value to the clinical isolates of E. coli and S. aureus collected from patients with urinary tract infection. S. aureus ATCC 25923 and E.coli ATCC 25922 were investigated in this study. Biofilm formation on polystyrene surface was conducted by growing bacterial isolates on 96-flat well microtiter plates, stained with crystal violet. The bound bacteria were quantified by addition of ethanol 70% and measurement of the dissolved crystal violet absorbance at (OD630 nm) using ELISA reader. Results: LL37 showed minimal inhibitory concentration (MIC) of 32 μg/ml against S. aureus and E. coli. The sub-MIC of LL37 was also able to eliminate about 31% and 34% of both S. aureus and E. coli, respectively. Anti-biofilm activity of LL37 showed biofilm inhibition at 1 μg/ml (1/32 MIC) to 16 μg/ml (1/2 MIC), which exhibited significant difference (p<0.001) against E. coli, whereas LL37 beyond 1 μg/ml showed significant inhibition (p<0.001) of biofilm against S. aureus. Conclusion: The cathelicidin LL37 can be used as a broad-spectrum anti-biofilm agent rather than killing agent. J Microbiol Infect Dis 2015;5(1): 15-20 Key words: Cathelicidin LL37, MIC, biofilm, anti-adhesive, killing rate
Authors and Affiliations
Safaa Toma Aka
Keywords
Related Articles
- EP ID EP127579
- DOI 10.5799/ahinjs.02.2015.01.0168
- Views 119
- Downloads 0
A Case of Chromobacterium violaceum
A Case of Chromobacterium violaceum Dolatsinh B. Zala, Vikram Khan, Ankush Ashokkumar Sanghai, Mustafa Vohra, V. K. Das Directorate of Medical & Health Services, UT of Dadra & Nagar Haveli, Silvassa, India ABSTRACT Infe...
First time isolation of Pseudomonas argentinensis from human skin infection
This reported the first isolation of Pseudomonas argentinensis from a human nfection, since the discovery of P. ar gentinensisin 2005. A Palestinian 63-year male practicing gardening on sunny days with exposed arms and l...
HPV genotyping: need of the hour for cervical cancer screening
Objectives: Cervical cancer is the most common cancer and leading cause of cancer deaths in women in developing countries. India shares about one-fourth of the global burden of cervical cancer and almost all cases harbou...
Detection of Streptobacillus moniliformis in whole blood by real-time PCR and review of clinical cases 2004-2015 in New York State
Objectives: Early identification of Streptobacillus moniliformis infections that cause rat bite fever (RBF) can be challenging and treatment of these infections is important for the reduction of morbidity and mortality....
Tümörü taklit eden primer hepatik aktinomikoz (Inflamatuar Psödotümör): Olgu sunumu ve literatür derlemesi
Aktinomikoz genellikle servikofasiyal bölgede abseler şeklinde ortaya çıkar. Karaciğer tutulumu çoğunlukla batın içi enfeksiyonlara ikincil olarak gelişir. “İzole veya Primer Hepatik Aktinomikoz (PHA)” başka bir enfeksiy...